|Mr. Bradley O'Connor B.Bus, CA||Chief Exec. Officer, MD & Exec. Director||N/A||N/A||N/A|
|Dr. Paul Maruff BBSc (Hons), Ph.D.||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. Lammert Albers||Chief Commercial Officer||793.27k||N/A||N/A|
|Ms. Claire Newstead-Sinclair BBus, CA||Fin. Director||N/A||N/A||N/A|
|Mr. Richard Gleeson||Chief Technology Officer||N/A||N/A||N/A|
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, and healthcare applications in Australia. The company offers cognition computerized tests and associated services, including scientific consultancy, project management, data management, statistical analysis, and reporting. It operates through four segments: Clinical Trials, Precision Recruitment, Healthcare, and Sports. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of disease and drugs; and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Precision Recruitment segment offers technology, which is used as an online screening tool as part of the process of recruiting subjects in clinical trials. The Healthcare segment provides technology and associated services as a tool for primary care physicians to assess cognitive decline. The Sports segment offers technology and associated services that are used to provide concussion management tools in sports. The company was founded in 1999 and is headquartered in Melbourne, Australia.
CogState Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.